Daniel Deangelo - Dissemin

Papers authored by Daniel Deangelo

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Evan C. Chen

, Helen Gandler, Isidora Tošić, Geoffrey G. Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J. DeAngelo

, Ilene Galinsky, Marlise R. Luskin

, Martha Wadleigh, Eric S. Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna Neuberg and 4 other authors

Data from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

Upload

Eytan M. Stein, Daniel J. DeAngelo

, Jörg Chromik, Manik Chatterjee, Sebastian Bauer, Chia-Chi Lin, Cristina Suarez, Filip de Vos, Neeltje Steeghs, Philippe A. Cassier, David Tai, Jean-Jacques Kiladjian, Noboru Yamamoto, Rogier Mous, Jordi Esteve and 10 other authors

Supplementary Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Upload

Eytan M. Stein, Daniel J. DeAngelo

Data from Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Upload

Hagop M. Kantarjian, Wendy Stock, Ryan D. Cassaday, Daniel J. DeAngelo

, Elias Jabbour, Susan M. O'Brien, Matthias Stelljes, Tao Wang, M. Luisa Paccagnella, Kevin Nguyen, Barbara Sleight, Erik Vandendries, Alexander Neuhof, A. Douglas Laird, Anjali S. Advani

Supplementary Data from Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22

Upload

Hagop M. Kantarjian, Wendy Stock, Ryan D. Cassaday, Daniel J. DeAngelo

, Elias Jabbour, Susan M. O'Brien, Matthias Stelljes, Tao Wang, M. Luisa Paccagnella, Kevin Nguyen, Barbara Sleight, Erik Vandendries, Alexander Neuhof, A. Douglas Laird, Anjali S. Advani

Data from Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 Evan C. Chen

, Helen Gandler

, Isidora Tošić

, Geoffrey G. Fell

, Ashlee Fiore

, Olga Pozdnyakova

, Daniel J. DeAngelo

, Ilene Galinsky

, Marlise R. Luskin

, Martha Wadleigh

, Eric S. Winer

, Rebecca Leonard

, Kelsey O'Day

, Adrienne de Jonge

, Donna Neuberg

and 4 other authors

Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

Upload

This paper is made freely available by the publisher.

Andreas Reiter, Juliana Schwaab, Daniel J. DeAngelo

, Jason Gotlib, Michael W. Deininger

, Kristen M. Pettit, Iván Alvarez-Twose, Alessandro M. Vannucchi

, Jens Panse

, Uwe Platzbecker

, Olivier Hermine, Ingunn Dybedal

, Hui-Min Lin, Svetlana N. Rylova, Katrin Ehlert and 2 other authors

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis

Download from doi.org

Distributing this paper is prohibited by the publisher

Jason Gotlib

, Andreas Reiter

, Daniel J. DeAngelo

Avapritinib for advanced systemic mastocytosis

Upload

Jurjen Versluis

, Manu Pandey, Yael Flamand, J. Erika Haydu

, Roger Belizaire

, Mark Faber

, Rahul S. Vedula

, Anne Charles, Kevin M. Copson, Shai Shimony

, Alon Rozental, Pavan K. Bendapudi, Ofir Wolach

, Elizabeth A. Griffiths

, James E. Thompson

and 6 other authors

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Download from ashpublications.org

Daniel J. DeAngelo

, Brian A. Jonas, Jane L. Liesveld, Dale L. Bixby, Anjali S. Advani

, Paula Marlton, John L. Magnani, Helen M. Thackray, Eric J. Feldman, Michael E. O’Dwyer

, Pamela S. Becker

Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia

Upload

Sarah B. Mueller

, Paola Dal Cin, Long P. Le, Dora Dias-Santagata, Jochen K. Lennerz

, A. John Iafrate, Hetal Desai Marble

, Andrew M. Brunner, Matthew J. Weinstock, Marlise R. Luskin

, Daniel J. De Angelo

, Richard M. Stone, Valentina Nardi

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity

Download from ashpublications.org

2021 Yannis K. Valtis

, Kristen E. Stevenson, Andrew E. Place

, Lewis B. Silverman, Lynda M. Vrooman, Giacomo Gotti

, Andrew M. Brunner, Mary Nauffal, Daniel J. DeAngelo

, Marlise R. Luskin

Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials

Download from doi.org

Jacqueline S. Garcia

, Haesook T. Kim, H. Moses Murdock

, Corey S. Cutler, Jennifer Brock, Mahasweta Gooptu, Vincent T. Ho, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Fiona Loschi, Jeremy Ryan

, Geoffrey Fell, Hannah Q. Karp and 10 other authors

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

Download from doi.org

Eytan M. Stein, Daniel J. DeAngelo

, Jörg Chromik, Manik Chatterjee, Sebastian Bauer

, Chia-Chi Lin

, Cristina Suarez, Filip de Vos

, Neeltje Steeghs, Philippe A. Cassier

, David Tai, Jean-Jacques Kiladjian, Noboru Yamamoto

, Rogier Mous, Jordi Esteve and 10 other authors

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Upload

Daniel J. DeAngelo

, Deepti H. Radia, Tracy I. George

, William A. Robinson, Albert T. Quiery, Mark W. Drummond, Prithviraj Bose

, Elizabeth O. Hexner

, Elliott F. Winton, Hans-Peter Horny, Meera Tugnait, Oleg Schmidt-Kittler, Erica K. Evans, Hui-Min Lin, Brenton G. Mar and 3 other authors

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Upload

Jason Gotlib

, Andreas Reiter, Deepti H. Radia, Michael W. Deininger

, Tracy I. George

, Jens Panse, Alessandro M. Vannucchi, Uwe Platzbecker

, Iván Alvarez-Twose, Andrzej Mital, Olivier Hermine, Ingunn Dybedal, Elizabeth O. Hexner

, Lisa K. Hicks, Lambert Span and 9 other authors

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Download from www.nature.com

Andrew Hantel

, Marlise R. Luskin

, Jacqueline S. Garcia

, Wendy Stock, Daniel J. DeAngelo

, Gregory A. Abel

Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials

Download from doi.org

Praveen Anand

, Amy Guillaumet-Adkins

, Valeriya Dimitrova

, Huiyoung Yun, Yotam Drier

, Noori Sotudeh, Anna Rogers

, Madhu M. Ouseph

, Monica Nair, Sayalee Potdar

, Randi Isenhart

, Jake A. Kloeber

, Tushara Vijaykumar, Leili Niu, Tiffaney Vincent and 12 other authors

Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL

Download from ashpublications.org

Blandine Roux

, Camille Vaganay, Jesse D. Vargas

, Gabriela Alexe

, Chaima Benaksas, Bryann Pardieu

, Nina Fenouille, Jana M. Ellegast

, Edyta Malolepsza, Frank Ling

, Gaetano Sodaro

, Linda Ross

, Yana Pikman

, Amy S. Conway

, Yangzhong Tang and 21 other authors

Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor

Upload

Hagop M. Kantarjian, Wendy Stock, Ryan D. Cassaday

, Daniel J. DeAngelo

, Elias Jabbour, Susan M. O'Brien, Matthias Stelljes, Tao Wang, M. Luisa Paccagnella, Kevin Nguyen, Barbara Sleight, Erik Vandendries, Alexander Neuhof, A. Douglas Laird, Anjali S. Advani

Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy and Safety by Baseline CD22

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Daniel Deangelo